Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Zhihuang HU"'
Autor:
Yao Zhang, Huiting Li, Bo Yu, Si Sun, Zhihuang Hu, Xianghua Wu, Yang Zhang, Bin Li, Yawei Zhang, Jiaqing Xiang, Jialei Wang, Hui Yu
Publikováno v:
Thoracic Cancer, Vol 15, Iss 13, Pp 1072-1081 (2024)
Abstract Background Neoadjuvant chemoimmunotherapy (NCIT) for locally advanced esophageal squamous cell carcinoma (ESCC) is supported by increasing data, but the sample size is limited, and the findings are not completely consistent. We conducted a r
Externí odkaz:
https://doaj.org/article/28952c6dc5f84d36b302c89a16803ffd
Autor:
Xin Zhang, Jiatao Liao, Wenyue Yang, Qiaojuan Li, Zhen Wang, Hui Yu, Xianghua Wu, Huijie Wang, Si Sun, Xinmin Zhao, Zhihuang Hu, Jialei Wang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe introduction of Immune Checkpoint Inhibitors (ICIs) has marked a paradigm shift in treating Lung Squamous Cell Carcinoma (LUSC), emphasizing the urgent need for precise molecular biomarkers to reliably forecast therapeutic efficacy. T
Externí odkaz:
https://doaj.org/article/cee5719076a84bd585e82480720124fe
Autor:
Chang Liu, Jiatao Liao, Xianghua Wu, Xinmin Zhao, Si Sun, Huijie Wang, Zhihuang Hu, Yao Zhang, Hui Yu, Jialei Wang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 10, Pp 1463-1470 (2022)
Abstract Background The aim of this prospective, pilot, single‐arm phase II trial was to evaluate the safety and efficacy of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small ce
Externí odkaz:
https://doaj.org/article/2637b6ff2dc5424eadb060b0d65faaff
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with poor survival, and platinum-etoposide chemotherapy is indicated as the mainstay of treatment. In this study, we compared the efficacy and safety betwee
Externí odkaz:
https://doaj.org/article/54fcbfd58fb34e3d91f63faefff64ed5
Autor:
Xinmin Zhao, Xianghua Wu, Hui Yu, Huijie Wang, Si Sun, Zhihuang Hu, Cuicui Liu, Junli Zhang, Yang Shao, Jialei Wang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe association between hematologic parameters and anti-programmed death-1 (PD-1) inhibitors was generally examined without considering therapy lines and medicine types. The study was aimed to identify potential hematologic biomarkers assoc
Externí odkaz:
https://doaj.org/article/19aa3c7a8e1746c799742399925146f9
Autor:
Chang Liu, Jinying Chen, Jiatao Liao, Yuchen Li, Hui Yu, Xinmin Zhao, Si Sun, Zhihuang Hu, Yao Zhang, Zhengfei Zhu, Min Fan, Shenglin Huang, Jialei Wang
Publikováno v:
Cancers, Vol 14, Iss 22, p 5493 (2022)
(1) Introduction: The aim of this study was to identify the plasma extracellular vesicle (EV)-specific transcriptional profile in small-cell lung cancer (SCLC) and to explore the application value of plasma EV long RNA (exLR) in SCLC treatment predic
Externí odkaz:
https://doaj.org/article/5512042f488448fda5448671681a39a2
Autor:
Yuan Quan, Fengji Liang, Deqing Wu, Xueqing Yao, Zhihuang Hu, Yuexing Zhu, Ying Chen, Andong Wu, Danian Tang, Bingyang Huang, Ruifeng Xu, Zejian Lyu, Qian Yan, Lang Luo, Zhengzhi Ning, Yong Li, Jianghui Xiong
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
There is a body of evidence that the aging immune system is linked to cancer. In this study, with aging- and immune-related DNA methylation data, we investigated the DNA methylation regulation changes in promoters with other regions of genes during a
Externí odkaz:
https://doaj.org/article/dc20c8f854254f64954226b1ae698246
Autor:
Junchao Cai, Lishan Fang, Yongbo Huang, Rong Li, Xiaonan Xu, Zhihuang Hu, Le Zhang, Yi Yang, Xun Zhu, Heng Zhang, Jueheng Wu, Yan Huang, Jun Li, Musheng Zeng, Erwei Song, Yukai He, Li Zhang, Mengfeng Li
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-19 (2017)
Chemoresistance and metastasis are tightly associated features in non-small cell lung cancer (NSCLC). Here, the authors show that resistant NSCLCs have high levels of miR-128-3p which promotes EMT and cancer stem cell survival through the modulation
Externí odkaz:
https://doaj.org/article/62ebaf9fb06e4953beda02cb7177db31
Autor:
Zhi Yang, Aiham Qdaisat, Zhihuang Hu, Elizabeth A Wagar, Cielito Reyes-Gibby, Qing H Meng, Sai-Ching J Yeung
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153492 (2016)
BACKGROUND:Septic shock may be associated with myocardial damage; however, the prognostic value of cardiac enzymes in cancer patients with septic shock is unknown. In this study, we evaluated the prognostic significance of cardiac enzymes in combinat
Externí odkaz:
https://doaj.org/article/5c2bf86d954c4dc3861ec6af6cd8427c
Autor:
Yan HUANG, Yunpeng LIU, Jianying ZHOU, Nong XU, Baolan LI, Gang WU, Jian FANG, Kai LI, Xiaoqing LIU, Wei LIU, You LU, Mengzhao WANG, Wenchao LIU, Houjie LIANG, Yiping ZHANG, Cheng HUANG, Shunjin WANG, Yajie WANG, Shiying YU, Jianhua CHANG, Zhehai WANG, Zhihuang HU, Li ZHANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 15, Iss 10, Pp 576-582 (2012)
Background and objective Platinum-based doublet chemotherapy is still the standard first-line treatment for non-small cell lung cancer (NSCLC). Previous studies have demonstrated that pemetrexed combined with platinum had promising efficacy and safet
Externí odkaz:
https://doaj.org/article/4c14d201c0624f859bf013e0770f297a